Diagnostic accuracy and clinical relevance of an inflammatory biomarker panel for sepsis in adult critically ill patients

Diagnostic Microbiology and Infectious Disease

Volumn 84, Issue 2, 2016, Pages 175-180

  Bauer, Philippe R ^a   Kashyap, Rahul ^a   League, Stacy C ^a   Park, John G ^a   Block, Darci R ^a   Baumann, Nikola A ^a   Algeciras Schimnich, Alicia ^a   Jenkins, Sarah M ^a   Smith, Carin Y ^a   Gajic, Ognjen ^a   Abraham, Roshini S ^a  

^a MAYO CLINIC   (United States)

Author keywords

C reactive protein; CD64; Procalcitonin; Sensitivity and specificity; Sepsis; Study of diagnostic accuracy

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD163 ANTIGEN; CD64 ANTIGEN; CELL MARKER; HLA DR ANTIGEN; PROCALCITONIN; CALCA PROTEIN, HUMAN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; MEMBRANE PROTEIN; PROTEIN PRECURSOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOCYTE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SEPSIS; BLOOD; BLOOD ANALYSIS; CHEMISTRY; CRITICAL ILLNESS; DOUBLE BLIND PROCEDURE; EVALUATION STUDY; LEUKOCYTE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; BLOOD CHEMICAL ANALYSIS; C-REACTIVE PROTEIN; CALCITONIN; CALCITONIN GENE-RELATED PEPTIDE; CRITICAL ILLNESS; DOUBLE-BLIND METHOD; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEPSIS;

EID: 84954392490     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2015.10.003     Document Type: Article

References (40)

1. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655.
2. Bossuyt P.M., Reitsma J.B., Bruns D.E., et al. Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med 2003, 138:40-44.
3. Bouadma L., Luyt C.E., Tubach F., et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010, 375:463-474.
4. Cardelli P., Ferraironi M., Amodeo R., et al. Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis. Int J Immunopathol Pharmacol 2008, 21:43-49.
5. Cid J., Aguinaco R., Sánchez R., García-Pardo G., Llorente A. Neutrophil CD64 expression as marker of bacterial infection: a systematic review and meta-analysis. J Infect 2010, 60:313-319.
6. Danikas D.D., Karakantza M., Theodorou G.L., Sakellaropoulos G.C., Gogos C.A. Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression. Clin Exp Immunol 2008, 154:87-97.
7. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
8. Dimoula A., Pradier O., Kassengera Z., Dalcomune D., Turkan H., Vincent J.L. Serial Determinations of Neutrophil CD64 Expression for the Diagnosis and Monitoring of Sepsis in Critically Ill Patients. Clin Infect Dis 2014, 58:820-829.
9. Fabriek B.O., van Bruggen R., Deng D.M., et al. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 2009, 113:887-892.
10. Fumeaux T., Pugin J. Is the measurement of monocytes HLA-DR expression useful in patients with sepsis?. Intensive Care Med 2006, 32:1106-1108.
11. Gibot S., Béné M.C., Noel R., et al. Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Respir Crit Care Med 2012, 186:65-71.
12. Gros A., Roussel M., Sauvadet E., et al. The sensitivity of neutrophil CD64 expression as a biomarker of bacterial infection is low in critically ill patients. Intensive Care Med 2012, 38:445-452.
13. Harris P.A., Taylor R., Thielke R., Payne J., Gonzalez N., Conde J.G. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009, 42:377-381.
14. Hirsh M., Mahamid E., Bashenko Y., Hirsh I., Krausz M.M. Overexpression of the high-affinity Fcgamma receptor (CD64) is associated with leukocyte dysfunction in sepsis. Shock 2001, 16:102-108.
15. Hsu K.H., Chan M.C., Wang J.M., Lin L.Y., Wu C.L. Comparison of Fcγ receptor expression on neutrophils with procalcitonin for the diagnosis of sepsis in critically ill patients. Respirology 2011, 16:152-160.
16. Icardi M., Erickson Y., Kilborn S., Stewart B., Grief B., Scharnweber G. CD64 index provides simple and predictive testing for detection and monitoring of sepsis and bacterial infection in hospital patients. J Clin Microbiol 2009, 47:3914-3919.
17. Kaukonen K.M., Bailey M., Suzuki S., Pilcher D., Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014, 311:1308-1316.
18. Kaukonen K.M., Bailey M., Pilcher D., Cooper D.J., Bellomo R. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med 2015, 372:1629-1638.
19. Kolaczkowska E., Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 2013, 13:159-175.
20. Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
21. Labarère J., Renaud B., Fine M.J. How to derive and validate clinical prediction models for use in intensive care medicine. Intensive Care Med 2014, 40:513-527.
22. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256.
23. Li S., Huang X., Chen Z., et al. Neutrophil CD64 expression as a biomarker in the early diagnosis of bacterial infection: a meta-analysis. Int J Infect Dis 2013, 17:e12-e23.
24. Livaditi O., Kotanidou A., Psarra A., et al. Neutrophil CD64 expression and serum IL-8: sensitive early markers of severity and outcome in sepsis. Cytokine 2006, 36:283-290.
25. Lord S.J., Irwig L., Simes R.J. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials?. Ann Intern Med 2006, 144:850-855.
26. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554.
27. Martin-Loeches I., Levy M.M., Artigas A. Management of severe sepsis: advances, challenges, and current status. Drug Des Devel Ther 2015, 9:2079-2088.
28. Monneret G., Lepape A., Voirin N., et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 2006, 32:1175-1183.
29. Reinhart K., Daniels R., Kissoon N., O'Brien J., Machado F.R., Jimenez E., et al. The burden of sepsis-a call to action in support of World Sepsis Day 2013. J Crit Care 2013, 28:526-528.
30. Samraj R.S., Zingarelli B., Wong H.R. Role of biomarkers in sepsis care. Shock 2013, 40:358-365.
31. Shankar-Hari M., Deutschman C.S., Singer M. Do we need a new definition of sepsis?. Intensive Care Med 2015, 41:909-911.
32. Simon L., Gauvin F., Amre D.K., Saint-Louis P., Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004, 39:206-217.
33. Steyerberg E.W., Harrell F.E., Borsboom G.J., Eijkemans M.J., Vergouwe Y., Habbema J.D. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001, 54:774-781.
34. Van Gorp H., Delputte P.L., Nauwynck H.J. Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy. Mol Immunol 2010, 47:1650-1660.
35. Vincent J.L., Moreno R., Takala J., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710.
36. Vincent J.L., Rello J., Marshall J., EPIC II Group of Investigators, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009, 302:2323-2329.
37. Wacker C., Prkno A., Brunkhorst F.M., Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013, 13:426-435.
38. Wang X., Li Z.Y., Zeng L., Zhang A.Q., Pan W., Gu W., et al. Neutrophil CD64 expression as a diagnostic marker for sepsis in adult patients: a meta-analysis. Crit Care 2015, 19:245.
39. Whiting P., Rutjes A.W., Reitsma J.B., Bossuyt P.M., Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25.
40. Zimmerman J.E., Kramer A.A., McNair D.S., Malila F.M. Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients. Crit Care Med 2006, 34:1297-1310.